These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 12880281
1. Optimization of an alum-adsorbed vaccine powder formulation for epidermal powder immunization. Maa YF, Shu C, Ameri M, Zuleger C, Che J, Osorio JE, Payne LG, Chen D. Pharm Res; 2003 Jul; 20(7):969-77. PubMed ID: 12880281 [Abstract] [Full Text] [Related]
2. Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application. Maa YF, Zhao L, Payne LG, Chen D. J Pharm Sci; 2003 Feb; 92(2):319-32. PubMed ID: 12532382 [Abstract] [Full Text] [Related]
3. Hepatitis-B surface antigen (HBsAg) powder formulation: process and stability assessment. Maa YF, Ameri M, Shu C, Zuleger CL, Che J, Osorio JE, Payne LG, Chen D. Curr Drug Deliv; 2007 Jan; 4(1):57-67. PubMed ID: 17269918 [Abstract] [Full Text] [Related]
4. A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution. Li X, Thakkar SG, Ruwona TB, Williams RO, Cui Z. J Control Release; 2015 Apr 28; 204():38-50. PubMed ID: 25735896 [Abstract] [Full Text] [Related]
5. Spray-coating for biopharmaceutical powder formulations: beyond the conventional scale and its application. Maa YF, Ameri M, Rigney R, Payne LG, Chen D. Pharm Res; 2004 Mar 28; 21(3):515-23. PubMed ID: 15070104 [Abstract] [Full Text] [Related]
6. Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation. Maa YF, Ameri M, Shu C, Payne LG, Chen D. J Pharm Sci; 2004 Jul 28; 93(7):1912-23. PubMed ID: 15176078 [Abstract] [Full Text] [Related]
7. A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation. Saluja V, Amorij JP, Kapteyn JC, de Boer AH, Frijlink HW, Hinrichs WL. J Control Release; 2010 Jun 01; 144(2):127-33. PubMed ID: 20219608 [Abstract] [Full Text] [Related]
8. Spray-freeze-drying for protein powder preparation: particle characterization and a case study with trypsinogen stability. Sonner C, Maa YF, Lee G. J Pharm Sci; 2002 Oct 01; 91(10):2122-39. PubMed ID: 12226840 [Abstract] [Full Text] [Related]
9. Improved storage stability and immunogenicity of hepatitis B vaccine after spray-freeze drying in presence of sugars. Tonnis WF, Amorij JP, Vreeman MA, Frijlink HW, Kersten GF, Hinrichs WL. Eur J Pharm Sci; 2014 May 13; 55():36-45. PubMed ID: 24468629 [Abstract] [Full Text] [Related]
10. Spray-freeze-drying of nanosuspensions: the manufacture of insulin particles for needle-free ballistic powder delivery. Schiffter H, Condliffe J, Vonhoff S. J R Soc Interface; 2010 Aug 06; 7 Suppl 4(Suppl 4):S483-500. PubMed ID: 20519207 [Abstract] [Full Text] [Related]
11. Stabilization of IgG1 in spray-dried powders for inhalation. Schüle S, Schulz-Fademrecht T, Garidel P, Bechtold-Peters K, Frieb W. Eur J Pharm Biopharm; 2008 Aug 06; 69(3):793-807. PubMed ID: 18477504 [Abstract] [Full Text] [Related]
12. Immune responses to hepatitis B surface antigen following epidermal powder immunization. Osorio JE, Zuleger CL, Burger M, Chu Q, Payne LG, Chen D. Immunol Cell Biol; 2003 Feb 06; 81(1):52-8. PubMed ID: 12534946 [Abstract] [Full Text] [Related]
13. Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants. Murugappan S, Patil HP, Kanojia G, ter Veer W, Meijerhof T, Frijlink HW, Huckriede A, Hinrichs WL. Eur J Pharm Biopharm; 2013 Nov 06; 85(3 Pt A):716-25. PubMed ID: 23933147 [Abstract] [Full Text] [Related]
14. Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs. Amidi M, Pellikaan HC, Hirschberg H, de Boer AH, Crommelin DJ, Hennink WE, Kersten G, Jiskoot W. Vaccine; 2007 Sep 17; 25(37-38):6818-29. PubMed ID: 17692440 [Abstract] [Full Text] [Related]
15. A pilot study using a novel pyrotechnically driven prototype applicator for epidermal powder immunization in piglets. Engert J, Anamur C, Engelke L, Fellner C, Lell P, Henke S, Stadler J, Zöls S, Ritzmann M, Winter G. Int J Pharm; 2018 Jul 10; 545(1-2):215-228. PubMed ID: 29684561 [Abstract] [Full Text] [Related]
16. Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine. Weissmueller NT, Marsay L, Schiffter HA, Carlisle RC, Rollier CS, Prud'homme RK, Pollard AJ. PLoS One; 2017 Jul 10; 12(8):e0183427. PubMed ID: 28837693 [Abstract] [Full Text] [Related]
17. Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01. Ingvarsson PT, Schmidt ST, Christensen D, Larsen NB, Hinrichs WL, Andersen P, Rantanen J, Nielsen HM, Yang M, Foged C. J Control Release; 2013 May 10; 167(3):256-64. PubMed ID: 23415813 [Abstract] [Full Text] [Related]
18. Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry. Huyge K, Van Reeth K, De Beer T, Landman WJ, van Eck JH, Remon JP, Vervaet C. Eur J Pharm Biopharm; 2012 Apr 10; 80(3):649-56. PubMed ID: 22155763 [Abstract] [Full Text] [Related]
19. Adjuvantation of epidermal powder immunization. Chen D, Erickson CA, Endres RL, Periwal SB, Chu Q, Shu C, Maa YF, Payne LG. Vaccine; 2001 Apr 06; 19(20-22):2908-17. PubMed ID: 11282202 [Abstract] [Full Text] [Related]
20. Pulmonary immunization of guinea pigs with diphtheria CRM-197 antigen as nanoparticle aggregate dry powders enhance local and systemic immune responses. Muttil P, Pulliam B, Garcia-Contreras L, Fallon JK, Wang C, Hickey AJ, Edwards DA. AAPS J; 2010 Dec 06; 12(4):699-707. PubMed ID: 20878294 [Abstract] [Full Text] [Related] Page: [Next] [New Search]